Scientific Strategy
The ICR Scientific Strategy 2010 – 2015 sets out the organisation’s research direction and describes how objectives will be delivered. The Strategy aims to develop key research areas while enhancing partnership affiliations.
Advancing the ICR’s research programmes is crucial to the Scientific Strategy. This is based on three interlinked themes: genetics and epidemiology, therapeutic development and molecular pathology. These areas of research are essential for personalised cancer medicine.
Building on the ICR’s relationship with The Royal Marsden NHS Foundation Trust (RM), through the development of the Marsden Comprehensive Cancer Centre, the Scientific Strategy aims to strengthen interactions within the clinical and translational settings.
Objectives:
- Maintaining, developing and exploiting the ICR and RM’s unique relationship to enhance cancer research.
- To ensure the ICR has a balanced portfolio of basic and applied research.
- To develop treatment regimes to the genetic makeup of the patient and tumour.
- To recruit, retain and motivate the best staff across the whole spectrum of the ICR’s activities.
